This invention concerns compounds for inhibiting intracellular signal transduction, especially intracellular signal transduction mediate by one or more molecular interactions involving a phosphotyrosine-containing protein. This invention also relates to pharmaceutic compositions containing the compounds and prophylactic and therapeutic methods involving pharmaceutical and veterinary administration of the compounds. The compounds are of formula (1) as defined herein. ##STR1##

Esta invenção concerne compostos para inibir o transduction intracellular do sinal, especial transduction intracellular do sinal intermediário por um ou mais interação molecular que envolve uma proteína phosphotyrosine-contendo. Esta invenção relaciona-se também às composições pharmaceutic que contêm os compostos e os métodos prophylactic e therapeutic que envolvem a administração pharmaceutical e veterinária dos compostos. Os compostos são da fórmula (1) como definido nisto. ## do ## STR1

 
Web www.patentalert.com

< Tumor necrosis factor receptor homologs and nucleic acids encoding the same

< Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods

> Protease inhibitors

> Uses for medical devices having a lubricious, nitric oxide-releasing coating

~ 00075